ACE and coronary artery disorder: Beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers, and calcium channel blockers were more widely used in these patients, while the proportion using thiazides was approximately equal in the two groups. Of the patients with CHD, 74.6% used ASA.